Added to YB: 2025-11-19
Pitch date: 2025-11-18
RPTX [bullish]
Repare Therapeutics Inc.
+18.83%
current return
Author Info
BiotechBonanza shares takes on biotech with a heavy focus on special situations. Sign up for the newsletter.
Company Info
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
Market Cap
$114.2M
Pitch Price
$2.23
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.03
P/E
-1.56
EV/Sales
0.17
Sector
Biotechnology
Category
special_situation
RPTX: An unbelievable CVR
RPTX: Xeno acquiring for $1.82/share cash + CVR containing 3 wholly-owned assets (1 Phase 3-ready), BMS partnership w/ $2.1B milestones across 7 programs, Debiopharm deal, 10% DCx stake. CVR trades ~1% of milestone value despite BMS adding 2 new programs in 2024, signaling continued interest.
Read full article (9 min)